Summary
The blood and urinary clearances of cis-diammine 1,1-cyclobutane dicarboxylate platinum(II) (CBDCA, JM8) were determined in four patients with malignancy. A 40 μCi iv injection of 191Pt/193Pt (3:1)-labelled CBDCA was followed by serial blood and urine sampling to 72h.
The blood clearance was triphasic, mean values for the fast, intermediate, and slow phases being 10.8 min, 2.5 h, and 125 h, respectively. The fraction of activity excreted in the urine within the first 6 h had a mean value of 66.7%, contrasting with 26.4% for cisplatin. There was only a small fraction of CBDCA excreted by the slow phase (1.5%) as against an average of 20% for CHIP and 27% for cisplatin.
The early and rapid renal clearance of CBDCA may account for reduced nephrotoxicity.
Similar content being viewed by others
References
Bruno S, Poster DS, Higby DJ, Burke P, Mittelman A (1980) Parameters of nephrotoxicity in relation to the administration of cis-DDP. Proc Am Assoc Cancer Res 21:150
Calvert AH, Harland SJ, Newell DR, Siddik ZH, Jones AC, McElwain TJ, Raju S, Wiltshaw E, Smith IE, Baker JM, Peckham MJ, Harrap KR, Cobley T (1982) Early clinical studies with cis-diammine 1,1-cyclobutane dicarboxylate platinum II. Cancer Chemother Pharmacol 9:140
Durant JR (1980) CisPlatin: A clinical overview. In: Prestayko AW, Crooke ST, Carter SK (eds) Cis-Platin: Current status and new developments. Academic Press, New York London Toronto Sydney San Francisco, pp 317–321
Harrap KR, Jones M, Wilkinson CR, Clink HMcD, Sparrow S, Mitchley BCV, Clake S, Veasey A (1980) Antitumour, toxic and biochemical properties of cisplantin and eight other platinum complexes. In: Prestayko AW, Crooke ST, Carter SK (eds) Cisplatin: Current status and new developments. Academic Press, New York London Toronto Sydney San Francisco, pp 193–212
Jones BR, Bhalla RB, Mladek J, Kaleya RN, Gralla RJ, Alcock NW, Schwartz MK, Young CW, Reidenberg MM (1980) Comparison of methods of evaluating nephrotoxicity of cisplatinum. Clin Pharmacol Ther 27:557
Nadler SB, Hidalgo JU, Bloch T (1962) Prediction of blood volume in normal human adults. Surgery 51:224–232
Siddik ZH, Newell R, Jones M, Boxall FE (1982) Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum (II) (CBDCA JM8) in mice and rats. Proc Am Assoc Cancer Res 23:168
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sharma, H., Thatcher, N., Baer, J. et al. Blood clearance of radioactively labelled cis-diammine 1,1-cyclobutane dicarboxylate platinum(II) (CBDCA) in cancer patients. Cancer Chemother. Pharmacol. 11, 5–7 (1983). https://doi.org/10.1007/BF00257407
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00257407